Impact of SARS-Cov2 Pandemic on Severity of Perioperative Complications in Patients Undergoing Appendectomy (SAP-19)

February 11, 2025 updated by: Laurent BRUNAUD, Central Hospital, Nancy, France
There are 2 types of surgical procedures to remove the appendix : open appendectomy or laparoscopic appendectomy. About 60000 appendectomies are performed every year in France. Early diagnosis of acute appendicitis is essential to prevent the risk of disease progression, leading to complicated appendicitis and an increased risk for mortality. Data regarding appendicitis management in the literature are numerous. However, the impact of COVID-19 pandemic on the management of those patients has led to a decrease in the number of visits for acute appendicitis (ER), but a higher proportion of complicated appendicitis, probably due to the patient's delayed decision to go to emergency department at the onset of clinical symptoms. Complicated appendicitis may also lead to an overuse of antibiotics, a longer hospital stay, and a higher global cost for the health system. This aim of this study was to evaluate whether this hypothesis was valid for the regional NANCY-METZ area (CHR Metz and CHRU Nancy). The main research hypothesis was that the pandemic caused by SARS-COVID 19 was significantly linked to an increased incidence of perioperative complications in patients who underwent an appendectomy for acute appendicitis in this region (North-east part of France).

Study Overview

Detailed Description

Appendix is a finger-like, blind-ended tube connected to the cecum. The most frequent disease regarding the appendix is appendicitis. Appendicitis is an inflammation of the appendix caused by an obstruction of the lumen of the appendix. This obstruction is most commonly due to an appendicolith (calcified "stone" made of feces). Inflamed lymphoid tissue from a viral infection, parasites, gallstone, or tumors may also cause the blockage. This blockage leads to an increased pressure in the appendix, leading to a decreased blood flow to the tissues of the appendix, and bacterial growth inside the appendix causing inflammation. The combination of inflammation, reduced blood flow to the appendix and distention of the appendix causes tissue injury and lead to infection and potentially necrosis. If this process is left untreated, the appendix may burst, releasing bacteria into the abdominal cavity, leading to a peritonitis with a potential impact on mortality rate. Appendicitis symptoms include right lower abdominal pain, nausea, vomiting, and decreased appetite. Complicated appendicitis is defined as perforated appendicitis, peri-appendicular abscess or peritonitis. Consequently, acute appendicitis is considered to be a surgical emergency.

There are 2 types of surgical procedures to remove the appendix : open appendectomy or laparoscopic appendectomy. About 60000 appendectomies are performed every year in France. Early diagnosis of acute appendicitis is essential to prevent the risk of disease progression, leading to complicated appendicitis and an increased risk for mortality. Data regarding appendicitis management in the literature are numerous. However, the impact of COVID-19 pandemic on the management of those patients has led to a decrease in the number of visits for acute appendicitis (ER), but a higher proportion of complicated appendicitis, probably due to the patient's delayed decision to go to emergency department at the onset of clinical symptoms. Complicated appendicitis may also lead to an overuse of antibiotics, a longer hospital stay, and a higher global cost for the health system. This aim of this study was to evaluate whether this hypothesis was valid for the regional NANCY-METZ area (CHR Metz and CHRU Nancy). The main research hypothesis was that the pandemic caused by SARS-COVID 19 was significantly linked to an increased incidence of perioperative complications in patients who underwent an appendectomy for acute appendicitis in this region (North-east part of France).

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nancy, France, 54511
        • CHRU Nancy - Département Chirurgie Viscérale, Métabolique et Cancérologique CVMC (7ème étage)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients managed at :

  • CHR Mercy
  • CHRU nancy

and who underwent appendectomy during the study period

Description

Inclusion Criteria:

  • patients who underwent appendectomy

Exclusion Criteria:

  • pregnancy
  • protection of vulnerable adults
  • disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control group without Covid 19 pandemic
- Patients who underwent an appendectomy from March 17, 2018 to December 14, 2018 and from March 17, 2019 to December 14, 2019
appendectomy for acute appendicitis
Test group with Covid 19 pandemic
- Patients who underwent an appendectomy from March 17, 2020 to December 14, 2020
appendectomy for acute appendicitis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative complications after appendectomy
Time Frame: from March 17 to December 14 (2020-2021 versus 2019-2018)
validated classification (Gomes classification)
from March 17 to December 14 (2020-2021 versus 2019-2018)
Postoperative complications after appendectomy
Time Frame: from March 17 to December 14 (2020-2021 versus 2019-2018)
validated classification (Clavien Dindo classification)
from March 17 to December 14 (2020-2021 versus 2019-2018)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delay before surgery
Time Frame: from March 17 to December 14 (2020-2021 versus 2019-2018)
Time duration from Symptoms onset and appendectomy
from March 17 to December 14 (2020-2021 versus 2019-2018)
Hospitalization duration
Time Frame: from March 17 to December 14 (2020-2021 versus 2019-2018)
Hospitalization duration
from March 17 to December 14 (2020-2021 versus 2019-2018)
Antibiotherapy duration
Time Frame: from March 17 to December 14 (2020-2021 versus 2019-2018)
Total antibiotherapy duration
from March 17 to December 14 (2020-2021 versus 2019-2018)
Biological inflammatory syndrom
Time Frame: from March 17 to December 14 (2020-2021 versus 2019-2018)
Hyperleucocytosis > 10000/mm3 and/or PCR > 100 mg/L
from March 17 to December 14 (2020-2021 versus 2019-2018)
Type of hospitalisation
Time Frame: from March 17 to December 14 (2020-2021 versus 2019-2018)
ward / ICU
from March 17 to December 14 (2020-2021 versus 2019-2018)
Delay between appedectomy and postoperative complications
Time Frame: from March 17 to December 14 (2020-2021 versus 2019-2018)
< 7 days; 7-30 days; > 30 days
from March 17 to December 14 (2020-2021 versus 2019-2018)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: laurent brunaud, Chru Nancy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 17, 2018

Primary Completion (Actual)

December 14, 2020

Study Completion (Actual)

October 1, 2024

Study Registration Dates

First Submitted

January 3, 2022

First Submitted That Met QC Criteria

January 3, 2022

First Posted (Actual)

January 5, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 11, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on appendectomy

Subscribe